Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

News > All

Total search results: 10149 | Ordered by Date (descending)
1 2 3 ... 100 101 102  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried. 2024-05-14
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. 2024-05-13
AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. 2024-05-13
ERS Genomics Ltd.. (5/13/24). "Press Release: ERS Genomics Appoints John E Milad as Chief Executive Officer". Stockholm. 2024-05-13
Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris. 2024-05-13
H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". 2024-05-13
iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies. 2024-05-10
BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel. 2024-05-07
Neurocare Group AG. (5/7/24). "Press Release: Neurocare Group AG Appoints Tariq El-Titi as Senior Vice President MENA, Strengthening Commitment to Middle East Health Sector". Dubai & Munich. 2024-05-07
CMR Surgical Ltd.. (5/7/24). "Press Release: CMR Surgical Appoints Shlomi Cohen as Chief Financial Officer". Cambridge. 2024-05-07
Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. 2024-05-07
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. 2024-05-07
Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. 2024-05-06
Medios AG. (5/6/24). "Press Release: Medios AG – Constantijn van Rietschoten Appointed Executive Board Member for International Markets". Berlin. 2024-05-06
ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne. 2024-05-06
Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried. 2024-05-06
Mariana Oncology Inc.. (5/2/24). "Press Release: Mariana Oncology to Be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer". Watertown, MA. 2024-05-02
Novartis AG. (5/2/24). "Press Release: Novartis Enters Agreement to Acquire Mariana Oncology, Strengthening Radioligand Therapy Pipeline". Basel. 2024-05-02
Sphere Fluidics Ltd.. (4/30/24). "Press Release: Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer". Cambridge. 2024-04-30
Evotec SE. (4/30/24). "Press Release: Bayer and Evotec Collaborate to Advance Precision Cardiology". Berlin & Hamburg. 2024-04-30
PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa. 2024-04-30
Avacta Group plc. (4/30/24). "Press Release: Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group". 2024-04-30
ProBioGen AG. (4/30/24). "Press Release: Change in Management". Berlin. 2024-04-30
Locate Bio Ltd.. (4/29/24). "Press Release: Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion". Nottingham. 2024-04-29
General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. 2024-04-29
Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. 2024-04-29
Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. 2024-04-29
Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil". 2024-04-26
Variantyx, Inc.. (4/26/24). "Press Release: Variantyx Secures $36M Investment as Testing Demand and Market Share Continues to Increase". Framingham, MA. 2024-04-26
Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY. 2024-04-26
Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt. 2024-04-25
Deepull Diagnostics S.L.. (4/25/24). "Press Release: Deepull Unveils 1 Hour, Direct-from-Blood Multiplex PCR Test for 95% of Sepsis-causing Pathogens at ESCMID 2024". Barcelona. 2024-04-25
CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. 2024-04-24
High-Tech Gründerfonds Management GmbH. (4/23/24). "Press Release: Cultimate Foods Raises 2.3 Million EUR Seed Funding from Leading Biotech and Foodtech Investors to Revolutionize the Alternative Meat Industry". Berlin. 2024-04-23
Seamless Therapeutics GmbH. (4/23/24). "Press Release: Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform". Dresden & Lexington, MA. 2024-04-23
Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg. 2024-04-23
Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. 2024-04-22
Neurolentech GmbH. (4/22/24). "Press Release: Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research". Klosterneuburg. 2024-04-22
Evotec SE. (4/18/24). "Press Release: Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments". Hamburg & Seattle, WA. 2024-04-18
Robert Bosch GmbH. (4/18/24). "Press Release: Additional Partnership in Medical Technology – Bosch and R-Biopharm to Strengthen Vivalytic Analysis platform". Darmstadt, Gerlingen & Waiblingen. 2024-04-18
Deepull Diagnostics S.L.. (4/18/24). "Press Release: Deepull Appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer". Barcelona. 2024-04-18
BioLizard N.V.. (4/18/24). "Press Release: BioLizard Appoints Matthew Hall as Director of Business Development". Lausanne & Ghent. 2024-04-18
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. 2024-04-17
Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA. 2024-04-17
NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA. 2024-04-17
Evotec SE. (4/17/24). "Press Release: Evotec Welcomes Aurélie Dalbiez as Chief People Officer". Hamburg. 2024-04-17
MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier. 2024-04-16
CureVac N.V.. (4/16/24). "Press Release: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines". Tübingen & Houston, TX. 2024-04-16
Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. 2024-04-15
KBI Biopharma, Inc.. (4/15/24). "Press Release: KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer". Durham, NC. 2024-04-15
Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel. 2024-04-11
Idorsia Ltd.. (4/11/24). "Press Release: Idorsia Takes Steps to Address Short-term Liquidity Needs". Allschwil. 2024-04-11
FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. 2024-04-11
Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY. 2024-04-11
TORL BioTherapeutics, LLC. (4/10/24). "Press Release: TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline". Los Angeles, CA. 2024-04-10
Robert Bosch GmbH. (4/10/24). "Press Release: Growth through Medical Technology – Bosch and Randox Invest Heavily in the Vivalytic Analysis Platform". Crumlin, Gerlingen & Waiblingen. 2024-04-10
CRS Clinical Research Services Management GmbH. (4/10/24). "Press Release: CRS Appoints Catherine Canales as New Chief Commercial Officer to Fuel Strategic Development and International Growth". Mannheim. 2024-04-10
Adrenomed AG. (4/10/24). "Press Release: AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock". Hennigsdorf. 2024-04-10
Sartorius AG. (4/9/24). "Press Release: Sartorius and TheWell Bioscience Partner to Enable more Accurate Predictions in Drug Discovery". Göttingen. 2024-04-09
Prothea Technologies Ltd.. (4/9/24). "Press Release: Prothea Technologies Launches with €12M Series A to Innovate Lung Cancer Diagnosis and Treatment". Edinburgh. 2024-04-09
Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA. 2024-04-09
BioCopy AG. (4/9/24). "Press Release: BioCopy Expands Corporate Portfolio with Acquisition of Perspix Biotech GmbH". Basel. 2024-04-09
Green Elephant Biotech GmbH. (4/9/24). "Press Release: Green Elephant Biotech Expands Sustainable 96-well Plate Line for Light-sensitive Experiments". Gießen. 2024-04-09
Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. 2024-04-09
Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf. 2024-04-05
Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil. 2024-04-04
Caris Life Sciences Inc.. (4/4/24). "Press Release: Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development". Irving, TX. 2024-04-04
Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA. 2024-04-04
EnteroBiotix Ltd.. (4/4/24). "Press Release: EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials". Glasgow. 2024-04-04
Addex Therapeutics S.A.. (4/3/24). "Press Release: Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders". Geneva & New York, NY. 2024-04-03
HealthTech For Care. (4/3/24). "Press Release: HealthTech For Care Launches Its European Patient Observatory to Accelerate Healthcare Equality in Europe". Paris. 2024-04-03
EnteroBiotix Ltd.. (4/3/24). "Press Release: EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS)". Glasgow. 2024-04-03
Alterome Therapeutics, Inc.. (4/3/24). "Press Release: Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives". San Diego, CA. 2024-04-03
Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. 2024-04-03
BioLizard N.V.. (4/2/24). "Press Release: BioLizard and AbnomX Announce Partnership". Ghent. 2024-04-02
BioGeneration Ventures B.V.. (4/2/24). "Press Release: BGV Appoints Peter Halle, PhD as Venture Partner". Amsterdam. 2024-04-02
Sparxell UK Ltd.. (4/2/24). "Press Release: Sparxell Raises $3.2m to Advance Development of Sustainable Pigments". Cambridge. 2024-04-02
Protembis GmbH. (4/2/24). "Press Release: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial". New York, NY & Aachen. 2024-04-02
Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel. 2024-04-02
Ipsen S.A.. (4/2/24). "Press Release: Ipsen and Sutro Biopharma Announce Exclusive Global Licensing Agreement for an ADC Targeting solid tumors". Paris & San Francisco, CA. 2024-04-02
Merz Asset Management Holding GmbH & Co. KG. (4/2/24). "Press Release: Merz Enters Asset Purchase Agreement with a US-based Biotech Company". Frankfurt am Main. 2024-04-02
NewAmsterdam Pharma Company N.V.. (4/1/24). "Press Release: NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer". Naarden & Miami, FL. 2024-04-01
TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (3/28/24). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheid für Neubau am Weinberg Campus. Förderung in Höhe von 14,7 Millionen Euro für neues Innovations- und Gründerzentrum in Halle 2024-03-28
ProBioGen AG. (3/27/24). "Press Release: ProBioGen and DioSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever". Berlin. 2024-03-27
SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris. 2024-03-27
Venturelab AG. (3/27/24). "Press Release: Venture Leaders Biotech 2024 – 10 Innovative Startups Selected for the Boston Roadshow". 2024-03-27
Innocent Meat GmbH. (3/26/24). "Press Release: Innocent Meat Raised EUR 3 Million". 2024-03-26
CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. 2024-03-26
ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin. 2024-03-26
Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. 2024-03-26
Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. 2024-03-25
Volumina Medical SA. (3/25/24). "Press Release: Volumina Medical Secures USD 21 Million Funding to Continue Its Clinical Program after Having Obtained Promising First in Human Data". Epalinges. 2024-03-25
A2 Biotherapeutics, Inc.. (3/25/24). "Press Release: A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors". Agoura Hills, CA. 2024-03-25
Kranus Health GmbH. (3/25/24). "Press Release: Kranus Health Increases Funding to USD 20 Million Total, Cementing Its Position as a Leader in Virtual Care in Urology". Berlin, Munich & Paris. 2024-03-25
Hemotune AG. (3/25/24). "Press Release: Hemotune Raises CHF 14 Million Series B2 Funding for Clinical Trials with the HemoSystem". Schlieren. 2024-03-25
OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD. 2024-03-25
Tricares SAS. (3/25/24). "Press Release: Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer". Paris & Munich. 2024-03-25
TNO. (3/25/24). "Press Release: TNO Launches Peregrion to Boost Market Impact of Its Technology that Accelerates Medicine Development". Leiden. 2024-03-25
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. 2024-03-21
Eisbach Bio GmbH. (3/21/24). "Press Release: Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors". Martinsried & Houston, TX. 2024-03-21
1 2 3 ... 100 101 102  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px

» top